Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A co-Administered With Zilbrix Hib and Polio Sabin

Trial Profile

Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A co-Administered With Zilbrix Hib and Polio Sabin

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Oct 2016

At a glance

  • Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Hib-DTP-hepatitis B vaccine; Poliovirus vaccine live oral
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Otitis media; Pertussis; Pneumococcal infections; Poliomyelitis; Tetanus
  • Focus Pharmacodynamics; Registrational
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 08 Dec 2011 Actual number of patients changed from 357 to 365 as reported by ClinicalTrials.gov. (Parent trial: NCT00678301)
    • 08 Jul 2010 Planned number of patients changed from 230 to 115 as reported by ClinicalTrials.gov.
    • 08 Jul 2010 Planned initiation date added to 1 Jul 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top